139 related articles for article (PubMed ID: 38040165)
21. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
[TBL] [Abstract][Full Text] [Related]
22. Potential role of poly(ADP-ribose) polymerase (PARP) activation in methotrexate-induced nephrotoxicity and tubular apoptosis.
Dalaklioglu S; Sahin P; Ordueri EG; Celik-Ozenci C; Tasatargil A
Int J Toxicol; 2012; 31(5):430-40. PubMed ID: 22914891
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
Ghosh U; Das N; Bhattacharyya NP
Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
[TBL] [Abstract][Full Text] [Related]
24. Poly(ADP-ribose) polymerase (PARP)-1-independent apoptosis-inducing factor (AIF) release and cell death are induced by eleostearic acid and blocked by alpha-tocopherol and MEK inhibition.
Kondo K; Obitsu S; Ohta S; Matsunami K; Otsuka H; Teshima R
J Biol Chem; 2010 Apr; 285(17):13079-91. PubMed ID: 20177052
[TBL] [Abstract][Full Text] [Related]
25. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.
Alano CC; Kauppinen TM; Valls AV; Swanson RA
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9685-90. PubMed ID: 16769901
[TBL] [Abstract][Full Text] [Related]
26. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
Dutto I; Sukhanova M; Tillhon M; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
[TBL] [Abstract][Full Text] [Related]
27. Visible light may directly induce nuclear DNA damage triggering the death pathway in RGC-5 cells.
Li GY; Fan B; Ma TH
Mol Vis; 2011; 17():3279-89. PubMed ID: 22194654
[TBL] [Abstract][Full Text] [Related]
28. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities.
Xu X; Sun B; Zhao C
Neurobiol Dis; 2023 Oct; 187():106314. PubMed ID: 37783233
[TBL] [Abstract][Full Text] [Related]
29. Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.
Laudisi F; Sambucci M; Pioli C
Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):326-33. PubMed ID: 21476963
[TBL] [Abstract][Full Text] [Related]
30. Regulation of poly(ADP-ribose) polymerase-1 functions by leukocyte elastase inhibitor/LEI-derived DNase II during caspase-independent apoptosis.
Leprêtre C; Scovassi AI; Shah GM; Torriglia A
Int J Biochem Cell Biol; 2009 May; 41(5):1046-54. PubMed ID: 18951996
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of mouse mu opioid receptor gene in neuronal cells by poly(ADP-ribose) polymerase-1.
Choi HS; Hwang CK; Kim CS; Song KY; Law PY; Loh HH; Wei LN
J Cell Mol Med; 2008 Dec; 12(6A):2319-33. PubMed ID: 18266974
[TBL] [Abstract][Full Text] [Related]
32. Nanosecond pulsed electric fields induce poly(ADP-ribose) formation and non-apoptotic cell death in HeLa S3 cells.
Morotomi-Yano K; Akiyama H; Yano K
Biochem Biophys Res Commun; 2013 Aug; 438(3):557-62. PubMed ID: 23899527
[TBL] [Abstract][Full Text] [Related]
33. FUS RRM regulates poly(ADP-ribose) levels after transcriptional arrest and PARP-1 activation on DNA damage.
Mamontova EM; Clément MJ; Sukhanova MV; Joshi V; Bouhss A; Rengifo-Gonzalez JC; Desforges B; Hamon L; Lavrik OI; Pastré D
Cell Rep; 2023 Oct; 42(10):113199. PubMed ID: 37804508
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.
Kwon M; Jang H; Kim EH; Roh JL
Cell Cycle; 2016 Nov; 15(22):3105-3114. PubMed ID: 27686740
[TBL] [Abstract][Full Text] [Related]
35. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.
Li N; Wang Y; Deng W; Lin SH
Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796
[TBL] [Abstract][Full Text] [Related]
36. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
Luo X; Kraus WL
Genes Dev; 2012 Mar; 26(5):417-32. PubMed ID: 22391446
[TBL] [Abstract][Full Text] [Related]
37. Mediation of cell death by poly(ADP-ribose) polymerase-1.
Koh DW; Dawson TM; Dawson VL
Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) polymerases: managing genome stability.
Meyer-Ficca ML; Meyer RG; Jacobson EL; Jacobson MK
Int J Biochem Cell Biol; 2005 May; 37(5):920-6. PubMed ID: 15743666
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.
Kauppinen TM; Gan L; Swanson RA
Biochim Biophys Acta; 2013 Aug; 1833(8):1985-91. PubMed ID: 23597856
[TBL] [Abstract][Full Text] [Related]
40. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis.
Simbulan-Rosenthal CM; Rosenthal DS; Iyer S; Boulares AH; Smulson ME
J Biol Chem; 1998 May; 273(22):13703-12. PubMed ID: 9593711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
